Literature DB >> 15866710

Expression of soluble, biologically active recombinant human endostatin in Escherichia coli.

Han-Mei Xu1, Guo-Yuan Zhang, Xiao-Dan Ji, Lin Cao, Luan Shu, Zi-Chun Hua.   

Abstract

Endostatin, a 20kDa C-terminal fragment of collagen XVIII, is a potent anti-angiogenic protein and inhibitor of tumor growth. Recombinant endostatin was prepared from Escherichia coli deposited as insoluble, inactive inclusion bodies. In the present study, we produced soluble and biologically active recombinant human endostatin (rhEndostatin) in E. coli by employing both co-expression of the molecular chaperones and lower temperature fermentation. Two groups of chaperones Trigger factor and GroEL-GroES (GroEL/ES), DnaK-DnaJ-GrpE and GroEL/ES, were co-expressed, respectively, with rhEndostatin at different temperatures (37, 25, and 16 degrees C). It revealed that low temperature or molecular chaperones alone could enhance the production of active rhEndostatin; meanwhile, combinational employment of low temperature cultivation (16 degrees C) together with co-expression of DnaK-DnaJ-GrpE and GroEL/ES was more effective to prevent aggregation of rhEndostatin. The production of soluble rhEndostatin was about 36 mg/L, and at least 16 mg of rhEndostatin was purified from 1L flask culture. The purified rhEndostatin specifically inhibited the proliferation of endothelial cell-bovine capillary endothelial cell in a dose-dependent manner, and it showed potent anti-angiogenic capability on the chorioallantoic membrane of chick embryo in vivo. Our study provides a feasible and convenient approach to produce soluble and biologically active rhEndostatin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866710     DOI: 10.1016/j.pep.2004.09.021

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  11 in total

Review 1.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

2.  Global transcriptome response of recombinant Escherichia coli to heat-shock and dual heat-shock recombinant protein induction.

Authors:  Sarah W Harcum; Fu'ad T Haddadin
Journal:  J Ind Microbiol Biotechnol       Date:  2006-05-06       Impact factor: 3.346

3.  Cloning and Expression of Recombinant Human Endostatin in Periplasm of Escherichia coli Expression System.

Authors:  Abbas Mohajeri; Yones Pilehvar-Soltanahmadi; Mohammad Pourhassan-Moghaddam; Jalal Abdolalizadeh; Pouran Karimi; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2016-06-30

4.  MR reporter gene imaging of endostatin expression and therapy.

Authors:  Kai Wang; Kezheng Wang; Baozhong Shen; Tao Huang; Xilin Sun; Weihua Li; Gang Jin; Lin Li; Lihong Bu; Renfei Li; Dan Wang; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2009-12-03       Impact factor: 3.488

5.  Molecular cloning, expression and purification of recombinant soluble mouse endostatin as an anti-angiogenic protein in Escherichia coli.

Authors:  Kheirollah Yari; Saboor Afzali; Hadi Mozafari; Kamran Mansouri; Ali Mostafaie
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

6.  Boosting the free fatty acid synthesis of Escherichia coli by expression of a cytosolic Acinetobacter baylyi thioesterase.

Authors:  Yanning Zheng; Lingling Li; Qiang Liu; Wen Qin; Jianming Yang; Yujin Cao; Xinglin Jiang; Guang Zhao; Mo Xian
Journal:  Biotechnol Biofuels       Date:  2012-10-11       Impact factor: 6.040

7.  Effects of E. coli chaperones on the solubility of human receptors in an in vitro expression system.

Authors:  Sumiyo Endo; Yusuke Tomimoto; Hiroyuki Shimizu; Yoshitaka Taniguchi; Takuo Onizuka
Journal:  Mol Biotechnol       Date:  2006-07       Impact factor: 2.860

8.  Enhanced serodiagnosis of melioidosis by indirect ELISA using the chimeric protein rGroEL-FLAG300 as an antigen.

Authors:  Sumet Wajanarogana; Water R J Taylor; Kanyanan Kritsiriwuthinan
Journal:  BMC Infect Dis       Date:  2022-04-19       Impact factor: 3.667

9.  Use of folding modulators to improve heterologous protein production in Escherichia coli.

Authors:  Olga Kolaj; Stefania Spada; Sylvain Robin; J Gerard Wall
Journal:  Microb Cell Fact       Date:  2009-01-27       Impact factor: 5.328

10.  Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli.

Authors:  Andrea Castellanos-Mendoza; Ricardo M Castro-Acosta; Alejandro Olvera; Guadalupe Zavala; Miguel Mendoza-Vera; Enrique García-Hernández; Alejandro Alagón; Mauricio A Trujillo-Roldán; Norma A Valdez-Cruz
Journal:  Microb Cell Fact       Date:  2014-09-12       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.